Validity Of The Patient-rated Forearm Evaluation Questionnaire As An Outcome Tool For Lateral Epicondylitis

作者
J. Preston Wiley,Bryan T. Chung
出处
期刊:Medicine and Science in Sports and Exercise [Lippincott Williams & Wilkins]
卷期号:37 (Supplement): S357-S357
标识
DOI:10.1249/00005768-200505001-01873
摘要

PURPOSE To assess the sensitivity to change of the Patient-Rated Forearm Evaluation Questionnaire (PRFEQ) for individuals with lateral epicondylitis (LE). METHODS 52 subjects who participated in a double-blind randomized control trial on the effectiveness of extracorporeal shockwave therapy (ESWT) in the treatment of lateral epicondylitis (LE) were administered the PRFEQ at 0, 4 and 8 weeks after initiation of therapy. All subjects had previously not received therapy for their LE. The PRFEQ has a highest possible score of 10 and lowest possible score of 0, where 0 indicates no pain and no difficulty in performing activities. Overall elbow pain (10cm visual analogue scale), quality of life (EuroQoL questionnaire) and grip strength were also evaluated. Subjects were classified as treatment successes or treatment non-successes based on the elbow pain VAS at 8 weeks. RESULTS The mean PRFEQ scores for treatment non-successes and treatment successes at baseline were 3.49 (SD=1.60) and 3.12 (SD=1.37) respectively. The mean PRFEQ scores for treatment non-successes and treatment successes at 8 weeks were 3.54 (SD=1.87) and 1.90 (SD=1.16) respectively. The mean change in score of the treatment non-success group was 0.5 with a 95% confidence interval of [0.1–0.9]. The mean change in score of the treatment success group was 1.6 with a 95% confidence interval of [1.2–2]. Test-retest reliability over 4 weeks, however, was poor (ICC=0.51) and the PRFEQ did not demonstrate acceptable item-specific convergent validity with similar or identical items in other validated tools. CONCLUSIONS The PRFEQ appears to be sensitive to clinically significant change in individuals with previously untreated lateral epicondylitis, but may not be a reliable outcome tool. Discrepancies between specific items of the PRFEQ and other measures of similar constructs may be related to the use of the visual numeric scale on the PRFEQ. Supported by the Alberta Provincial CIHR Bone and Joint Training Program and the Sport Science Association of Alberta.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坚强思烟发布了新的文献求助10
刚刚
gzl发布了新的文献求助10
1秒前
dg发布了新的文献求助10
1秒前
1秒前
桐桐应助海豹妮妮采纳,获得10
1秒前
共享精神应助时肆万采纳,获得10
2秒前
2秒前
aaaa应助明亮夜云采纳,获得20
2秒前
酷波er应助jjj采纳,获得10
3秒前
3秒前
3秒前
明亮翼完成签到,获得积分20
3秒前
是我呀吼发布了新的文献求助10
3秒前
3秒前
pauder发布了新的文献求助10
3秒前
Lucas应助无奈的书琴采纳,获得10
4秒前
4秒前
5秒前
NexusExplorer应助段尚英采纳,获得10
5秒前
5秒前
6秒前
哎呀呀完成签到,获得积分10
6秒前
沉默傲薇完成签到,获得积分10
6秒前
稳重元菱发布了新的文献求助30
7秒前
NexusExplorer应助科研小白采纳,获得30
7秒前
苹果以云发布了新的文献求助10
7秒前
豆沙饭团发布了新的文献求助10
7秒前
outlander完成签到,获得积分10
8秒前
8秒前
8秒前
难过丹寒发布了新的文献求助10
8秒前
9秒前
天天快乐应助zz采纳,获得10
9秒前
科研通AI6.2应助七七采纳,获得10
9秒前
义气鲂发布了新的文献求助10
9秒前
超级的丹琴完成签到,获得积分10
10秒前
木通完成签到,获得积分10
10秒前
顾矜应助结实的中道采纳,获得10
10秒前
王俊凯老婆完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Industrial Hydraulics Manual (7th edition) 800
Physiologic races of the downy mildew fungus on soybeans in North Carolina 800
Rosenblum, Global Change Biology 800
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7775167
求助须知:如何正确求助?哪些是违规求助? 9317096
关于积分的说明 20354787
捐赠科研通 7361481
什么是DOI,文献DOI怎么找? 3317913
关于科研通互助平台的介绍 2466137
邀请新用户注册赠送积分活动 2333218